NCT02911077

Brief Summary

Background: Many bacteria live in the gut. The gut is the tube that moves food from the mouth through the stomach to the intestines. Heavy alcohol use disturbs these bacteria. There is evidence that the bacteria in the gut may affect anxiety and depression. Researchers want to learn more about these bacteria in order to better treat diseases such as alcohol dependence. Objective: To identify the different bacteria that live in the mouth and gut. Also, to learn if these bacteria change as a person goes through alcohol detoxification. Eligibility: People ages 18 and older who:

  • Enrolled in screening protocol 14-AA-0181
  • Are going through detoxification treatment at the Clinical Center Design: Participants will have physical exams. Participants will answer questions about:
  • Anxiety and depression
  • Alcohol use
  • Sleep
  • Abdominal and oral health
  • Diet Participants will keep a regular record of their diet. Participants will have breath alcohol analysis 4 times per day. Participants will provide stool and oral specimens at most once a day for the first week. Then, they will provide them once a week while they are at the Clinical Center.
  • For the oral specimen: A small brush rubs the tongue. They may not eat, drink, or perform oral care within 2 hours of collection.
  • For the stool specimen: They will receive a container that fits in the toilet. They will let the nurse know right away when the sample is ready. Participants will have a dental visit. This consists of an oral exam and oral health assessment. The dentist may recommend a cleaning or dental X-rays.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2016

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 21, 2016

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 22, 2016

Completed
5 days until next milestone

Study Start

First participant enrolled

September 27, 2016

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 29, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 29, 2017

Completed
Last Updated

May 1, 2026

Status Verified

January 16, 2026

Enrollment Period

11 months

First QC Date

September 21, 2016

Last Update Submit

April 30, 2026

Conditions

Keywords

BacteriaNatural History

Outcome Measures

Primary Outcomes (1)

  • Identification of bacteria in the gut and oral microbiomes over time

    Characterization of the gut and oral micro biome

    all timepoints

Study Arms (1)

AUD population

The participants/group were treatment-seeking AUD individuals admitted to the NIH CC 1SE Addictions Unit.

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

inpatient treatment seeking alcohol dependent participants

You may qualify if:

  • At least 18 years of age
  • Willing to provide consent
  • Consented on screening and research protocol 14-AA-0181
  • Admitted to the NIH CC for inpatient detoxification treatment

You may not qualify if:

  • Currently using or have used any of the following drugs within the last month by self-report:
  • Antibiotics
  • Corticosteroids: inhaled, oral, intravenous or intramuscular
  • Immunosuppressive or cytotoxic agents
  • Large doses of probiotics such as supplemental probiotics (ordinary dietary components such as beverages/milk or yogurt DO NOT APPLY)
  • Any bowel resection at any time.
  • History of active uncontrolled gastrointestinal disorders or diseases including inflammatory bowel disease, ulcerative colitis, Crohn s disease, and/or infectious gastroenteritis, colitis, or gastritis (per patient s report of whether or not they have been diagnosed by a physician).
  • Enrolled in any investigational study that might affect the microbiome.
  • BMI greater than or equal to 30 kg/m2

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institutes of Health Clinical Center

Bethesda, Maryland, 20892, United States

Location

Related Links

MeSH Terms

Conditions

Alcoholic IntoxicationAlcohol-Related Disorders

Condition Hierarchy (Ancestors)

Substance-Related DisordersChemically-Induced DisordersMental Disorders

Study Officials

  • Katherine A Maki, C.R.N.P.

    National Institutes of Health Clinical Center (CC)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 21, 2016

First Posted

September 22, 2016

Study Start

September 27, 2016

Primary Completion

August 29, 2017

Study Completion

August 29, 2017

Last Updated

May 1, 2026

Record last verified: 2026-01-16

Locations